Overview
Compre Group buys and manages old insurance policies that other insurers no longer want to handle, operating in the run-off (legacy) market. It does not write new policies; instead it acquires diversified portfolios of existing liabilities and oversees the ongoing claims handling and asset management. Its differentiators include a focused legacy-book strategy backed by private equity and a stable management team, enabling expansion into regions like the US and Lloyd's of London. The goal is to grow through acquisitions of legacy books, generate returns from managed liabilities, and provide insurers with certainty and capital relief by closing out past obligations.
Work here?Claim your company
Simplify's take
What believers are saying
- Compre returned to profitability in 2025 and deployed $456 million gross acquired reserves.
- March 2026 deals added Amerisure asbestos liabilities and a £250 million European ADC.
- The Covéa acquisition gave Compre a US carrier platform for North American expansion.
What critics are saying
- Leadership churn hit CRO earlier in 2026; Compre replaced him in October and November.
- PwC counted only 13 H1 2026 run-off deals, signaling a thinner market.
- Prospective underwriting and legacy acquisitions stretch governance; one bad pricing cycle can destroy capital.
What makes Compre Group unique
- Compre buys discontinued insurance books, not new policies, and extracts value from reserves.
- In 2025, Compre completed nine transactions, including Covéa carriers and Ethias liabilities.
- Pallas Re now mixes legacy deals, ADCs, and prospective quota shares across regions.
Help us improve and share your feedback! Did you find this helpful?